nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00621	0.00621	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Repaglinide—type 2 diabetes mellitus	0.00617	0.00617	CcSEcCtD
Cisatracurium Besylate—Injury—Gliclazide—type 2 diabetes mellitus	0.00615	0.00615	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00599	0.00599	CcSEcCtD
Cisatracurium Besylate—Wheezing—Irbesartan—type 2 diabetes mellitus	0.00597	0.00597	CcSEcCtD
Cisatracurium Besylate—Erythema—Repaglinide—type 2 diabetes mellitus	0.00595	0.00595	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00584	0.00584	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00582	0.00582	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.00537	0.00537	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Pioglitazone—type 2 diabetes mellitus	0.00532	0.00532	CcSEcCtD
Cisatracurium Besylate—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00529	0.00529	CcSEcCtD
Cisatracurium Besylate—Flushing—Glipizide—type 2 diabetes mellitus	0.00525	0.00525	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Sitagliptin—type 2 diabetes mellitus	0.00517	0.00517	CcSEcCtD
Cisatracurium Besylate—Injury—Metformin—type 2 diabetes mellitus	0.00514	0.00514	CcSEcCtD
Cisatracurium Besylate—Angioedema—Rosiglitazone—type 2 diabetes mellitus	0.00514	0.00514	CcSEcCtD
Cisatracurium Besylate—Hypertension—Repaglinide—type 2 diabetes mellitus	0.00514	0.00514	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.00503	0.00503	CcSEcCtD
Cisatracurium Besylate—Erythema—Glipizide—type 2 diabetes mellitus	0.00492	0.00492	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Pioglitazone—type 2 diabetes mellitus	0.00489	0.00489	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00488	0.00488	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00486	0.00486	CcSEcCtD
Cisatracurium Besylate—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.00486	0.00486	CcSEcCtD
Cisatracurium Besylate—Injury—Irbesartan—type 2 diabetes mellitus	0.00485	0.00485	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.00485	0.00485	CcSEcCtD
Cisatracurium Besylate—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00481	0.00481	CcSEcCtD
Cisatracurium Besylate—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00481	0.00481	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Sitagliptin—type 2 diabetes mellitus	0.00477	0.00477	CcSEcCtD
Cisatracurium Besylate—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00476	0.00476	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Sitagliptin—type 2 diabetes mellitus	0.00475	0.00475	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00474	0.00474	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.00472	0.00472	CcSEcCtD
Cisatracurium Besylate—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00471	0.00471	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Bromocriptine—type 2 diabetes mellitus	0.00468	0.00468	CcSEcCtD
Cisatracurium Besylate—Rash—Miglitol—type 2 diabetes mellitus	0.00467	0.00467	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00466	0.00466	CcSEcCtD
Cisatracurium Besylate—Urticaria—Acarbose—type 2 diabetes mellitus	0.00462	0.00462	CcSEcCtD
Cisatracurium Besylate—Erythema—Glimepiride—type 2 diabetes mellitus	0.00459	0.00459	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00459	0.00459	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Valsartan—type 2 diabetes mellitus	0.00458	0.00458	CcSEcCtD
Cisatracurium Besylate—Injury—Losartan—type 2 diabetes mellitus	0.00457	0.00457	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.0045	0.0045	CcSEcCtD
Cisatracurium Besylate—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00446	0.00446	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00442	0.00442	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00436	0.00436	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Bromocriptine—type 2 diabetes mellitus	0.00432	0.00432	CcSEcCtD
Cisatracurium Besylate—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.00431	0.00431	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00429	0.00429	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00429	0.00429	CcSEcCtD
Cisatracurium Besylate—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00428	0.00428	CcSEcCtD
Cisatracurium Besylate—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00428	0.00428	CcSEcCtD
Cisatracurium Besylate—Hypertension—Glipizide—type 2 diabetes mellitus	0.00425	0.00425	CcSEcCtD
Cisatracurium Besylate—Angioedema—Glimepiride—type 2 diabetes mellitus	0.0042	0.0042	CcSEcCtD
Cisatracurium Besylate—Rash—Tolbutamide—type 2 diabetes mellitus	0.0042	0.0042	CcSEcCtD
Cisatracurium Besylate—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.00418	0.00418	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00413	0.00413	CcSEcCtD
Cisatracurium Besylate—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.00407	0.00407	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.00399	0.00399	CcSEcCtD
Cisatracurium Besylate—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00398	0.00398	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.00398	0.00398	CcSEcCtD
Cisatracurium Besylate—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00397	0.00397	CcSEcCtD
Cisatracurium Besylate—Hypertension—Glimepiride—type 2 diabetes mellitus	0.00397	0.00397	CcSEcCtD
Cisatracurium Besylate—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.00395	0.00395	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Irbesartan—type 2 diabetes mellitus	0.00393	0.00393	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.00387	0.00387	CcSEcCtD
Cisatracurium Besylate—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00386	0.00386	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00385	0.00385	CcSEcCtD
Cisatracurium Besylate—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00382	0.00382	CcSEcCtD
Cisatracurium Besylate—Rash—Tolazamide—type 2 diabetes mellitus	0.00382	0.00382	CcSEcCtD
Cisatracurium Besylate—Erythema—Glyburide—type 2 diabetes mellitus	0.00379	0.00379	CcSEcCtD
Cisatracurium Besylate—Rash—Linagliptin—type 2 diabetes mellitus	0.00378	0.00378	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00378	0.00378	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00377	0.00377	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00375	0.00375	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.00374	0.00374	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00374	0.00374	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.00372	0.00372	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Losartan—type 2 diabetes mellitus	0.0037	0.0037	CcSEcCtD
Cisatracurium Besylate—Rash—Acarbose—type 2 diabetes mellitus	0.00367	0.00367	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00367	0.00367	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00367	0.00367	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00366	0.00366	CcSEcCtD
Cisatracurium Besylate—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00365	0.00365	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00363	0.00363	CcSEcCtD
Cisatracurium Besylate—Flushing—Gliclazide—type 2 diabetes mellitus	0.00363	0.00363	CcSEcCtD
Cisatracurium Besylate—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00359	0.00359	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.00358	0.00358	CcSEcCtD
Cisatracurium Besylate—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.00358	0.00358	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00358	0.00358	CcSEcCtD
Cisatracurium Besylate—Rash—Nateglinide—type 2 diabetes mellitus	0.00354	0.00354	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00353	0.00353	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Valsartan—type 2 diabetes mellitus	0.00353	0.00353	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.0035	0.0035	CcSEcCtD
Cisatracurium Besylate—Hypotension—Glimepiride—type 2 diabetes mellitus	0.0035	0.0035	CcSEcCtD
Cisatracurium Besylate—Angioedema—Glyburide—type 2 diabetes mellitus	0.00346	0.00346	CcSEcCtD
Cisatracurium Besylate—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00344	0.00344	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00343	0.00343	CcSEcCtD
Cisatracurium Besylate—Erythema—Gliclazide—type 2 diabetes mellitus	0.0034	0.0034	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.00334	0.00334	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Metformin—type 2 diabetes mellitus	0.00333	0.00333	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00332	0.00332	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.0033	0.0033	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00329	0.00329	CcSEcCtD
Cisatracurium Besylate—Convulsion—Glyburide—type 2 diabetes mellitus	0.00328	0.00328	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Valsartan—type 2 diabetes mellitus	0.00326	0.00326	CcSEcCtD
Cisatracurium Besylate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00325	0.00325	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.00324	0.00324	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.00324	0.00324	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.00321	0.00321	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.0032	0.0032	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.0032	0.0032	CcSEcCtD
Cisatracurium Besylate—Urticaria—Glipizide—type 2 diabetes mellitus	0.00319	0.00319	CcSEcCtD
Cisatracurium Besylate—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00316	0.00316	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00314	0.00314	CcSEcCtD
Cisatracurium Besylate—Angioedema—Gliclazide—type 2 diabetes mellitus	0.00311	0.00311	CcSEcCtD
Cisatracurium Besylate—Rash—Repaglinide—type 2 diabetes mellitus	0.00306	0.00306	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00306	0.00306	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00306	0.00306	CcSEcCtD
Cisatracurium Besylate—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00306	0.00306	CcSEcCtD
Cisatracurium Besylate—Flushing—Metformin—type 2 diabetes mellitus	0.00303	0.00303	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00303	0.00303	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.00303	0.00303	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00302	0.00302	CcSEcCtD
Cisatracurium Besylate—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00298	0.00298	CcSEcCtD
Cisatracurium Besylate—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00297	0.00297	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Metformin—type 2 diabetes mellitus	0.00297	0.00297	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00296	0.00296	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00295	0.00295	CcSEcCtD
Cisatracurium Besylate—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00295	0.00295	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.00295	0.00295	CcSEcCtD
Cisatracurium Besylate—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00294	0.00294	CcSEcCtD
Cisatracurium Besylate—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00289	0.00289	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00289	0.00289	CcSEcCtD
Cisatracurium Besylate—Hypotension—Glyburide—type 2 diabetes mellitus	0.00289	0.00289	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00288	0.00288	CcSEcCtD
Cisatracurium Besylate—Flushing—Irbesartan—type 2 diabetes mellitus	0.00286	0.00286	CcSEcCtD
Cisatracurium Besylate—Angioedema—Valsartan—type 2 diabetes mellitus	0.00286	0.00286	CcSEcCtD
Cisatracurium Besylate—Erythema—Metformin—type 2 diabetes mellitus	0.00285	0.00285	CcSEcCtD
Cisatracurium Besylate—Pruritus—Glipizide—type 2 diabetes mellitus	0.00284	0.00284	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00284	0.00284	CcSEcCtD
Cisatracurium Besylate—Angioedema—Orlistat—type 2 diabetes mellitus	0.00282	0.00282	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.0028	0.0028	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00279	0.00279	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.00278	0.00278	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00276	0.00276	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00276	0.00276	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00275	0.00275	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00272	0.00272	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00271	0.00271	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.0027	0.0027	CcSEcCtD
Cisatracurium Besylate—Flushing—Losartan—type 2 diabetes mellitus	0.0027	0.0027	CcSEcCtD
Cisatracurium Besylate—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00269	0.00269	CcSEcCtD
Cisatracurium Besylate—Erythema—Irbesartan—type 2 diabetes mellitus	0.00269	0.00269	CcSEcCtD
Cisatracurium Besylate—Convulsion—Orlistat—type 2 diabetes mellitus	0.00268	0.00268	CcSEcCtD
Cisatracurium Besylate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00265	0.00265	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00264	0.00264	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Losartan—type 2 diabetes mellitus	0.00263	0.00263	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00261	0.00261	CcSEcCtD
Cisatracurium Besylate—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00259	0.00259	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00255	0.00255	CcSEcCtD
Cisatracurium Besylate—Rash—Glipizide—type 2 diabetes mellitus	0.00253	0.00253	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00253	0.00253	CcSEcCtD
Cisatracurium Besylate—Erythema—Losartan—type 2 diabetes mellitus	0.00253	0.00253	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00252	0.00252	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.0025	0.0025	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00248	0.00248	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00248	0.00248	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00247	0.00247	CcSEcCtD
Cisatracurium Besylate—Hypertension—Metformin—type 2 diabetes mellitus	0.00246	0.00246	CcSEcCtD
Cisatracurium Besylate—Urticaria—Glyburide—type 2 diabetes mellitus	0.00246	0.00246	CcSEcCtD
Cisatracurium Besylate—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00245	0.00245	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00245	0.00245	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.00245	0.00245	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00241	0.00241	CcSEcCtD
Cisatracurium Besylate—Hypotension—Valsartan—type 2 diabetes mellitus	0.00238	0.00238	CcSEcCtD
Cisatracurium Besylate—Rash—Glimepiride—type 2 diabetes mellitus	0.00236	0.00236	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00236	0.00236	CcSEcCtD
Cisatracurium Besylate—Rash—Sitagliptin—type 2 diabetes mellitus	0.00236	0.00236	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00235	0.00235	CcSEcCtD
Cisatracurium Besylate—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00232	0.00232	CcSEcCtD
Cisatracurium Besylate—Flushing—Ramipril—type 2 diabetes mellitus	0.00231	0.00231	CcSEcCtD
Cisatracurium Besylate—Angioedema—Losartan—type 2 diabetes mellitus	0.00231	0.00231	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00228	0.00228	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00228	0.00228	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00227	0.00227	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00227	0.00227	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Metformin—type 2 diabetes mellitus	0.00226	0.00226	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00225	0.00225	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.00224	0.00224	CcSEcCtD
Cisatracurium Besylate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00221	0.00221	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00219	0.00219	CcSEcCtD
Cisatracurium Besylate—Pruritus—Glyburide—type 2 diabetes mellitus	0.00219	0.00219	CcSEcCtD
Cisatracurium Besylate—Hypotension—Metformin—type 2 diabetes mellitus	0.00217	0.00217	CcSEcCtD
Cisatracurium Besylate—Erythema—Ramipril—type 2 diabetes mellitus	0.00217	0.00217	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00215	0.00215	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00214	0.00214	CcSEcCtD
Cisatracurium Besylate—Rash—Bromocriptine—type 2 diabetes mellitus	0.00213	0.00213	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00213	0.00213	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00213	0.00213	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00207	0.00207	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00206	0.00206	CcSEcCtD
Cisatracurium Besylate—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Cisatracurium Besylate—Urticaria—Valsartan—type 2 diabetes mellitus	0.00203	0.00203	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Losartan—type 2 diabetes mellitus	0.00201	0.00201	CcSEcCtD
Cisatracurium Besylate—Urticaria—Orlistat—type 2 diabetes mellitus	0.002	0.002	CcSEcCtD
Cisatracurium Besylate—Angioedema—Ramipril—type 2 diabetes mellitus	0.00198	0.00198	CcSEcCtD
Cisatracurium Besylate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00196	0.00196	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00195	0.00195	CcSEcCtD
Cisatracurium Besylate—Rash—Glyburide—type 2 diabetes mellitus	0.00195	0.00195	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00195	0.00195	CcSEcCtD
Cisatracurium Besylate—Hypotension—Losartan—type 2 diabetes mellitus	0.00193	0.00193	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Cisatracurium Besylate—Convulsion—Ramipril—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00186	0.00186	CcSEcCtD
Cisatracurium Besylate—Urticaria—Metformin—type 2 diabetes mellitus	0.00185	0.00185	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00184	0.00184	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00183	0.00183	CcSEcCtD
Cisatracurium Besylate—Pruritus—Valsartan—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Cisatracurium Besylate—Pruritus—Orlistat—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00177	0.00177	CcSEcCtD
Cisatracurium Besylate—Rash—Gliclazide—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Cisatracurium Besylate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00173	0.00173	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00173	0.00173	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00172	0.00172	CcSEcCtD
Cisatracurium Besylate—Hypotension—Ramipril—type 2 diabetes mellitus	0.00165	0.00165	CcSEcCtD
Cisatracurium Besylate—Pruritus—Metformin—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Cisatracurium Besylate—Urticaria—Losartan—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Cisatracurium Besylate—Rash—Valsartan—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Cisatracurium Besylate—Rash—Orlistat—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Cisatracurium Besylate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Cisatracurium Besylate—Rash—Metformin—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Metformin—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Cisatracurium Besylate—Pruritus—Losartan—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Cisatracurium Besylate—Urticaria—Ramipril—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Cisatracurium Besylate—Rash—Irbesartan—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Cisatracurium Besylate—Rash—Losartan—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Losartan—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Cisatracurium Besylate—Pruritus—Ramipril—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Cisatracurium Besylate—Rash—Ramipril—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
